Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Combined With Capeox Chemotherapy, Sintilimab and Suvemcitug in Locally Advanced pMMR Rectal Cancer
NCT07774754Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Sep 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of suvemcitug in rectal cancer, sponsored by Sun Yat-sen University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
suvemcitug
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07774754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07774754.